Research Topics
| Catherine A FullertonSummaryAffiliation: Harvard University Country: USA Publications
|
Detail Information
Publications
The rise and fall of gabapentin for bipolar disorder: a case study on off-label pharmaceutical diffusionCatherine A Fullerton
Department of Health Care Policy, Harvard Medical School, 180 Longwood Avenue, Boston, MA 02478, USA
Med Care 48:372-9. 2010..The case of gabapentin use in bipolar disorder provides an opportunity to study the roles of marketing, clinical evidence, and prior authorization (PA) policy on off-label medication use...
Medication use and spending trends among children with ADHD in Florida's Medicaid program, 1996-2005Catherine A Fullerton
Department of Health Care Policy, Harvard Medical School, and Brigham and Women s Hospital, 180 Longwood Ave, Boston, MA 02115, USA
Psychiatr Serv 63:115-21. 2012..This study examined trends in use of pharmaceuticals and their costs among children with ADHD from 1996 to 2005...
Trends in mental health admissions to nursing homes, 1999-2005Catherine Anne Fullerton
Department of Health Care Policy, Harvard Medical School, 180 Longwood Ave, Boston, MA 02115, USA
Psychiatr Serv 60:965-71. 2009..The study examined 1999-2005 data on first-time nursing home admissions of individuals with mental illness, dementia, or both to identify trends and characteristics...
Ten-year trends in quality of care and spending for depression: 1996 through 2005Catherine A Fullerton
Department of Health Care Policy, Harvard Medical School, Boston, MA 02115, USA
Arch Gen Psychiatry 68:1218-26. 2011....
Intended and unintended consequences of the gabapentin off-label marketing lawsuit among patients with bipolar disorderMeredith J Chace
Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care, 133 Brookline Ave, 6th Floor, Boston, MA 02215, USA
J Clin Psychiatry 73:1388-94. 2012....
